Literature DB >> 33350450

Burden of Respiratory Syncytial Virus Infection During the First Year of Life.

Emilia Thomas1, Janna-Maija Mattila1, Pasi Lehtinen1, Tytti Vuorinen2,3, Matti Waris2,3, Terho Heikkinen1.   

Abstract

BACKGROUND: Although many infants with respiratory syncytial virus (RSV) infection are hospitalized, most infants are treated as outpatients. Limited data are available on the burden of RSV in outpatient infants.
METHODS: In a prospective study, we enrolled 431 newborn infants and followed them up for a 10-month period (September-June). During each respiratory illness, we examined the infants and obtained nasopharyngeal specimens for the detection of RSV. The parents completed daily symptom diaries throughout the study.
RESULTS: Among 408 active participants, the seasonal incidence rate of RSV illness was 328.4 per 1000 (95% confidence interval [CI], 275.2-389.0). Infants with ≥1 sibling had a 1.9-fold higher incidence of RSV illness than those without siblings (95% CI, 1.3-2.8; P < .001). Acute otitis media developed in 103 (76.9%) of 134 infants with RSV infection, and 95 (70.9%) were treated with antibiotics. Nine infants with RSV (6.7%) were hospitalized, for a seasonal incidence rate of RSV hospitalization of 22.1 per 1000 (95% CI, 10.1-41.9).
CONCLUSIONS: The outpatient burden of RSV is heavy on infants during the first year of life. Acute otitis media is a frequent complication of RSV, and it should be included in cost-effectiveness analyses of prevention or treatment of RSV infections in infants.
© The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  antiviral agents; burden of illness; infant; monoclonal antibodies; respiratory syncytial virus; vaccines

Mesh:

Year:  2021        PMID: 33350450     DOI: 10.1093/infdis/jiaa754

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  7 in total

1.  Global burden of upper respiratory infections in 204 countries and territories, from 1990 to 2019.

Authors:  Xuting Jin; Jiajia Ren; Ruohan Li; Ya Gao; Haoying Zhang; Jiamei Li; Jingjing Zhang; Xiaochuang Wang; Gang Wang
Journal:  EClinicalMedicine       Date:  2021-06-28

2.  Respiratory syncytial virus in pediatric influenza-like illness cases in Lombardy, Northern Italy, during seven consecutive winter seasons (from 2014-2015 to 2020-2021).

Authors:  Laura Pellegrinelli; Cristina Galli; Laura Bubba; Arlinda Seiti; Giovanni Anselmi; Valeria Primache; Lucia Signorini; Serena Delbue; Sandro Binda; Elena Pariani
Journal:  Influenza Other Respir Viruses       Date:  2021-12-17       Impact factor: 4.380

3.  Prevention of antimicrobial prescribing among infants following maternal vaccination against respiratory syncytial virus.

Authors:  Joseph A Lewnard; Louis F Fries; Iksung Cho; Janice Chen; Ramanan Laxminarayan
Journal:  Proc Natl Acad Sci U S A       Date:  2022-03-14       Impact factor: 11.205

4.  Clinical Burden of Respiratory Syncytial Virus in Hospitalized Children Aged ≤5 Years (INSPIRE Study).

Authors:  Katrin Hartmann; Johannes G Liese; Daniel Kemmling; Christiane Prifert; Benedikt Weißbrich; Pushpike Thilakarathne; Joris Diels; Karin Weber; Andrea Streng
Journal:  J Infect Dis       Date:  2022-08-26       Impact factor: 7.759

5.  Clinico demographic profiling of the Respiratory syncytial virus (RSV) infected children admitted in tertiary care hospital in North India.

Authors:  Charu Singh; Suresh Kumar Angurana; Ishani Bora; Neha Jain; Kanwalpreet Kaur; Subhabrata Sarkar
Journal:  J Family Med Prim Care       Date:  2021-05-31

6.  Role of G2-S16 Polyanionic Carbosilane Dendrimer in the Prevention of Respiratory Syncytial Virus Infection In Vitro and In Vivo in Mice.

Authors:  Ignacio Rodriguez-Izquierdo; Rafael Ceña-Diez; Maria Jesús Serramia; Rosa Rodriguez-Fernández; Isidoro Martínez; Mariángeles Muñoz-Fernández
Journal:  Polymers (Basel)       Date:  2021-06-29       Impact factor: 4.329

7.  The importance of viral testing in infants and young children with bronchiolitis.

Authors:  Asuncion Mejias; Maria I Sanchez-Codez; Octavio Ramilo; Pablo J Sanchez
Journal:  J Pediatr (Rio J)       Date:  2022-03-10       Impact factor: 2.990

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.